Glioblastoma multiforme

Open Access
COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells
JUYEONG PARK, JOO YEON JEONG and SANG SOO KANG

Anticancer Research December 2022, 42 (12) 5773-5781; DOI: https://doi.org/10.21873/anticanres.16084
You have access
Establishment of a Novel Temozolomide Resistant Subline of Glioblastoma Multiforme Cells and Comparative Transcriptome Analysis With Parental Cells
HAI-ANH HA, JAI-SING YANG, FUU-JEN TSAI, CHANG-WEI LI, YIH-DIH CHENG, JIANYONG LI, MANN-JEN HOUR and YU-JEN CHIU

Anticancer Research May 2021, 41 (5) 2333-2347; DOI: https://doi.org/10.21873/anticanres.15008
You have access
A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme
DIRK RADES, JASPAR WITTELER, STEVEN E. SCHILD, PETER TRILLENBERG, MATTEO M. BONSANTO and JAN LEPPERT

Anticancer Research January 2021, 41 (1) 379-384; DOI: https://doi.org/10.21873/anticanres.14786
You have access
Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM)
JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES

Anticancer Research December 2020, 40 (12) 7025-7030; DOI: https://doi.org/10.21873/anticanres.14728
You have access
Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature
RUDOLF LIKAR, MARKUS KOESTENBERGER, MARTIN STULTSCHNIG and GERHARD NAHLER

Anticancer Research October 2019, 39 (10) 5797-5801; DOI: https://doi.org/10.21873/anticanres.13783
You have access
Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion
LAWRENCE HELSON and MUHAMMED MAJEED

Anticancer Research July 2019, 39 (7) 3423-3427; DOI: https://doi.org/10.21873/anticanres.13487
You have access
Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
MARKOS ANTONOPOULOS, STEFAAN W. VAN GOOL, DIMITRA DIONYSIOU, NORBERT GRAF and GEORGIOS STAMATAKOS

Anticancer Research April 2019, 39 (4) 2043-2051; DOI: https://doi.org/10.21873/anticanres.13315
You have access
Brainstem Glioblastoma Multiforme in a Patient with NF1
JOHN T. FORTUNATO, BRIAN REYS, PAWAN SINGH and EDWARD PAN

Anticancer Research August 2018, 38 (8) 4897-4900; DOI: https://doi.org/10.21873/anticanres.12804
You have access
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme
JIRI POLIVKA, JIRI POLIVKA, LUBOS HOLUBEC, TEREZA KUBIKOVA, VLADIMIR PRIBAN, ONDREJ HES, KRISTYNA PIVOVARCIKOVA and INKA TRESKOVA

Anticancer Research January 2017, 37 (1) 21-33;
You have access
ITPP Treatment of RG2 Glioblastoma in a Rat Model
KAROLINA FÖRNVIK, SHAIAN ZOLFAGHARI, LEIF G. SALFORD and HENRIETTA NITTBY REDEBRANDT

Anticancer Research November 2016, 36 (11) 5751-5755;

Main menu

User menu

Search

Glioblastoma multiforme

Pages